Foxo1 selectively regulates static mechanical pain by interacting with Nav1.7

Area of Science:

• Neuroscience
• Pain Research
• Molecular Biology

Background:

• Mechanical allodynia, a form of chronic pain, significantly impacts patient quality of life.
• Distinct subtypes of mechanical allodynia, dynamic and static, present unique clinical challenges.
• The forkhead protein Foxo1 is crucial for neuronal function, but its role in somatosensation is largely unknown.

Purpose of the Study:

• To investigate the specific role of Foxo1 in regulating static mechanical pain.
• To elucidate the molecular mechanisms underlying Foxo1's involvement in pain signaling.
• To explore the potential of Foxo1 as a biomarker and therapeutic target for chronic pain.

Main Methods:

• Utilized knockdown and overexpression techniques for Foxo1 in rat models of various pain conditions.
• Examined the interaction between Foxo1 and voltage-gated sodium Nav1.7 channels in dorsal root ganglia neurons.
• Measured serum Foxo1 levels in chronic pain patients and correlated them with pain severity.

Main Results:

• Foxo1 knockdown reduced sensitivity to static mechanical stimuli and attenuated allodynia in multiple pain models.
• Foxo1 overexpression selectively enhanced static mechanical sensitivity and induced allodynia.
• Foxo1 directly interacts with Nav1.7 channels, increasing current density by accelerating activation without altering channel expression.

Conclusions:

• Foxo1 is a key regulator of static mechanical pain, acting via interaction with Nav1.7 channels.
• Elevated serum Foxo1 levels correlate with chronic pain severity, suggesting its potential as a diagnostic biomarker.
• Targeting the Foxo1/Nav1.7 interaction presents a promising therapeutic strategy for mechanical pain management.